Home›Stock Screener›Healthcare Global Enterprises

Healthcare Global Enterprises Share Price Today | Stock Price & Healthcare Global Enterprises Share Screener

HCG Hospitals
Live Share Price NSE
₹669.05
▲ 0.30 (0.04%)
2026-10-05 00:00:00
Live Share Price BSE
₹668.75
▲ 0.65 (0.10%)
2026-10-05 00:00:00

As of October 5, 2026, the live Healthcare Global Enterprises share price (NSE: HCG) is ₹669.05 on NSE and ₹668.75 on BSE, up 0.04% from the previous close, with shares trading between ₹658.65 and ₹670.90 in today's trading session, and a 52-week range of ₹521.75–₹776.30. Check Healthcare Global Enterprises 52-week for the annual price range and momentum. Use the Healthcare Global Enterprises stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Healthcare Global Enterprises opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹664 and net income of ₹4, with EBITDA of ₹105, an operating margin of 14.0% and a profit margin of 0.6%.

Healthcare Global Enterprises Market Cap ₹10,378.00 Cr.
HCG P/E Ratio (TTM) 310.47
Healthcare Global Enterprises P/B Ratio 7.76
EPS (TTM) ₹0.97
Dividend Yield -
Debt to Equity 1.58
HCG 52 Week High ₹776.30
Healthcare Global Enterprises 52 Week Low ₹521.75
Operating Margin 14.00%
Profit Margin 0.60%
HCG Revenue (TTM) ₹664.00
EBITDA ₹105.00
Net Income ₹4.00
Total Assets ₹3,923.00
Total Equity ₹1,410.00

Healthcare Global Enterprises Share Price Chart

Track the current stock price of Healthcare Global Enterprises with an interactive chart. Analyse HCG share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Healthcare Global Enterprises stock quote in one place.

The quote of ₹669.05 sits between the 52-week low of ₹521.75 and the 52-week high of ₹776.30, and the latest session moved 0.04% from the previous close.

Healthcare Global Enterprises Company Profile - Fundamental Screener

Screen Healthcare Global Enterprises company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for HCG shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare Services sector and the Hospitals industry, and it trades under ISIN INE075I01017.

Company Details

Classification

Sector Healthcare Services
Industry Hospitals
Sub-Sector Hospitals
Segment E

Identifiers and Leadership

ISIN INE075I01017

Healthcare Global Enterprises Balance Sheet Screener

Screen HCG balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹3,923, up from ₹3,543 in 2025.

Latest statistics put total assets at ₹3,923 and shareholder funds at ₹1,410, with a leverage ratio of 1.58.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 3,923 3,543 2,708 2,316 2,220 2,036 2,253 1,654 1,444 1,226
Current Assets 1,135 844 680 580 502 435 304 273 220 244
Fixed Assets 2,462 2,442 1,758 1,553 1,547 1,382 1,646 970 828 685

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 1,495 1,507 1,099 876 866 856 1,258 584 506 371
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 1,410 990 865 869 884 714 420 522 579 490
Share Capital 149 139 139 139 139 125 89 88 87 86
Reserves & Surplus 1,183 783 687 721 731 528 293 389 398 347

Healthcare Global Enterprises Income Statement Screener - Profit & Revenue Analysis

Screen Healthcare Global Enterprises income statement and profit fundamentals. Analyze HCG quarterly results. Healthcare Global Enterprises reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹664 and net profit was ₹4, equal to earnings per unit of ₹0.15, at an operating margin of 14%.

In that period expenses were ₹559, interest cost ₹43 and tax ₹-3. The next period listed, 2026-Jun, shows revenue of ₹707 and net profit of ₹17.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar

Revenue and Expenses

Revenue 664 707 594 619 648 634 502 534 564 563 446 463 489 475 367
Expenses 559 573 480 505 524 536 403 435 451 470 365 386 402 391 302

Operating Costs and Margins

EBITDA 105 134 114 114 125 98 100 99 112 93 80 76 87 84 65
Operating Profit % 14.00% 17.00% 18.00% 17.00% 19.00% 15.00% 18.00% 17.00% 18.00% 16.00% 17.00% 16.00% 17.00% 17.00% 17.00%
Depreciation 63 70 58 58 63 61 46 47 50 57 42 41 43 44 41
Interest 43 40 44 46 44 45 27 34 36 41 26 26 27 30 24

Profit and Earnings

Profit Before Tax 1 25 14 12 20 -6 28 19 28 -3 13 11 18 11 1
Tax -3 9 7 6 -1 2 5 5 7 -11 8 7 7 8 -1
Net Profit 4 17 7 6 21 -8 24 14 21 8 6 4 11 3 2
EPS 0.15 0.92 0.53 0.34 1.16 -0.68 1.53 0.87 1.29 0.50 0.60 0.55 0.97 0.41 0.43

Healthcare Global Enterprises Cash Flow Screener - Liquidity Fundamentals

Screen HCG cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹347, and net cash flow was an inflow of ₹410.

Over the same period, investing activities used ₹178 and financing activities provided ₹241.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 347 317 285 252 220 121 130 99 98 91
Investing Activities -178 -488 -226 -133 125 -171 -101 -238 -283 -210

Financing and Net Cash

Financing Activities 241 -42 -64 -140 -155 112 -58 84 161 89
Net Cash Flow 410 -213 -5 -22 190 62 -30 -56 -24 -29

Healthcare Global Enterprises Shareholding Pattern Screener

See Healthcare Global Enterprises shareholding pattern with promoter, FII, and DII holdings. Check Healthcare Global Enterprises promoter holding and ownership changes for HCG on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 64.21%, foreign institutions 2.75%, domestic institutions 18.91% and the public 10.79%, spread across 47,576 shareholders.

The shareholder count was 47,576 in 2026-Mar, compared with 48,905 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 64.21% 64.21% 71.22% 62.46% 63.78% 63.77% 71.28% 71.25%

Institutional Investors

FII Holding 2.75% 2.74% 2.45% 2.16% 3.59% 3.22% 6.74% 3.95%
DII Holding 18.91% 19.20% 12.47% 13.22% 18.36% 18.30% 8.52% 10.89%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 10.79% 10.83% 10.43% 10.50% 10.41% 11.20% 9.39% 9.41%
Other Holding 3.34% 3.02% 3.43% 11.66% 3.86% 3.51% 4.07% 4.49%
Shareholder Count 47,576 48,905 45,394 47,028 46,970 45,366 27,195 26,529

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Healthcare Global Enterprises. Healthcare Global Enterprises dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Healthcare Global Enterprises.

Healthcare Global Enterprises Stock Index Membership - Nifty & Sensex

See which indices include Healthcare Global Enterprises stock. Check HCG index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 5 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX SMLCAP, NIFTY MICROCAP250.

Complete Index List

BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
NIFTY MICROCAP250
NIFTY TOTAL MKT

Healthcare Global Enterprises Market Events Screener - Corporate Actions

Get Healthcare Global Enterprises corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Healthcare Global Enterprises stock events that may affect HCG share price, along with derivatives, futures and options activity and sector gainers.

12 corporate actions are listed, the most recent entry being Annual General Meeting dated September 18, 2026, with a record date of September 18, 2026.

It is followed by Quarterly Result Announcement dated August 6, 2026 and Quarterly Result Announcement dated May 19, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-18 2026-09-18 Annual General Meeting NA -2.36%
2026-08-06 2026-08-06 Quarterly Result Announcement NA 0.47%
2026-05-19 2026-05-19 Quarterly Result Announcement NA 10.43%
2026-03-02 2026-03-02 Rights 1:17 -2.88%
2026-02-05 2026-02-05 Quarterly Result Announcement NA -3.32%
2025-11-12 2025-11-12 Quarterly Result Announcement NA -2.45%
2025-09-25 2025-09-25 Annual General Meeting NA -6.34%
2025-08-01 2025-08-01 Quarterly Result Announcement NA 9.83%
2025-05-24 2025-05-24 Quarterly Result Announcement NA 7.76%
2025-02-14 2025-02-14 Quarterly Result Announcement NA -3.65%
2024-11-09 2024-11-09 Quarterly Result Announcement NA 9.06%
2024-09-25 2024-09-25 Annual General Meeting NA 5.32%

Healthcare Global Enterprises Competitors Screener - Peer Stocks Comparison

Screen HCG competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Apollo Hospitals 126,581 58.67 25,420 15.58% 2,003 50.96
Max Healthcare Institute 96,507 66.86 8,536 18.82% 1,442 40.71
Aster DM Quality Care 65,101 179.76 4,769 11.25% 427 40.99
Fortis Healthcare 62,035 58.65 9,179 16.93% 1,064 27.19
Global Health 37,970 69.81 4,509 19.56% 554 46.95
Narayana Hrudayalaya 37,030 45.50 7,996 43.43% 811 41.22
Krishna Institute of Medical Sciences 32,595 165.49 3,931 28.16% 242 43.81
Dr. Agarwal's Health Care 15,572 86.39 2,125 20.92% 168 50.48
Rainbow Childrens Medicare 13,911 48.05 1,747 11.49% 282 32.52
Park Medi World 11,792 40.25 1,711 19.99% 274 42.43

Healthcare Global Enterprises Company Announcements - News & Reports Screener

Screen HCG latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 26, 2026.

The next most recent announcements are dated September 26, 2026 and September 17, 2026.

Date Update Actions
2026-09-26 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-26 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-17 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-16 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-09 Intimation Of Grant Of Employee Stock Options Under Healthcare Global Enterprises Limited- Employee Stock Option Scheme 2026 -
2026-08-28 Letter To Members Of The Company Containing Weblink And Path Of Integrated Annual Report For The Financial Year 2025-26. -
2026-08-28 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-27 Notice Of 28Th Annual General Meeting Of The Company For FY 2025-26. -
2026-08-27 Reg. 34 (1) Annual Report. -
2026-08-27 Business Responsibility and Sustainability Reporting (BRSR) -
2026-08-25 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-10 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-08-08 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-07 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-08-07 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-08-06 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-08-06 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-08-06 Announcement under Regulation 30 (LODR)-Monitoring Agency Report -
2026-08-06 Statement Of Variation Or Deviation Of The Proceeds Of Rights Issue For The Quarter Ended June 30 2026. -
2026-08-06 Announcement under Regulation 30 (LODR)-Change in Management -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹669.05, within a 52-week range of ₹521.75 to ₹776.30. The P/E ratio is 310.47 and the P/B ratio is 7.76, with earnings per unit of ₹0.97. Market capitalisation stands at ₹10,378.00 Cr. The company operates in the Healthcare Services sector, in the Hospitals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.